Trade GlaxoSmithKline plc - GSK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 39.06 |
| Open | 39.76 |
| 1-Year Change | 11.5% |
| Day's Range | 39.75 - 40.06 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 39.01 | 0.13 | 0.33% | 38.88 | 39.40 | 38.86 |
| Jul 24, 2024 | 39.24 | 0.41 | 1.06% | 38.83 | 39.24 | 38.80 |
| Jul 23, 2024 | 38.78 | -0.40 | -1.02% | 39.18 | 39.18 | 38.70 |
| Jul 22, 2024 | 39.34 | -0.03 | -0.08% | 39.37 | 39.52 | 39.25 |
| Jul 19, 2024 | 39.31 | 0.20 | 0.51% | 39.11 | 39.40 | 39.06 |
| Jul 18, 2024 | 39.29 | -0.37 | -0.93% | 39.66 | 39.77 | 39.21 |
| Jul 17, 2024 | 39.76 | 0.65 | 1.66% | 39.11 | 39.88 | 39.07 |
| Jul 16, 2024 | 38.85 | 0.40 | 1.04% | 38.45 | 38.90 | 38.40 |
| Jul 15, 2024 | 38.62 | -0.41 | -1.05% | 39.03 | 39.04 | 38.60 |
| Jul 12, 2024 | 39.11 | -0.19 | -0.48% | 39.30 | 39.45 | 39.08 |
| Jul 11, 2024 | 38.84 | 0.07 | 0.18% | 38.77 | 38.97 | 38.67 |
| Jul 10, 2024 | 38.51 | 0.03 | 0.08% | 38.48 | 38.59 | 38.40 |
| Jul 9, 2024 | 38.55 | -0.10 | -0.26% | 38.65 | 38.82 | 38.46 |
| Jul 8, 2024 | 38.66 | -0.14 | -0.36% | 38.80 | 38.89 | 38.47 |
| Jul 5, 2024 | 38.78 | 0.00 | 0.00% | 38.78 | 38.85 | 37.90 |
| Jul 3, 2024 | 38.38 | 0.31 | 0.81% | 38.07 | 38.43 | 38.07 |
| Jul 2, 2024 | 38.15 | 0.12 | 0.32% | 38.03 | 38.26 | 37.73 |
| Jul 1, 2024 | 38.32 | -0.03 | -0.08% | 38.35 | 39.01 | 38.26 |
| Jun 28, 2024 | 38.44 | -0.18 | -0.47% | 38.62 | 38.95 | 38.40 |
| Jun 27, 2024 | 38.60 | 0.26 | 0.68% | 38.34 | 38.73 | 38.15 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
GlaxoSmithKline Company profile
About GlaxoSmithKline plc (ADR)
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, GlaxoSmithKline plc (ADR) revenues increased less than 1% to £34.11B. Net income decreased 24% to £4.39B. Revenues reflect Pharmaceuticals segment increase of 4% to £17.73B, US segment increase of 4% to £15.09B, also reflect Consumer Healthcare segment decrease of 4% to £9.61B, Vaccines segment decrease of 3% to £6.78B, Unallocated segment decrease from £28M to £0K.
Equity composition
Ordinary Shs. 25p Par, 05/11, 10B auth., 5,657,488,184 issd., less 494,074,284 Treas. shs. @ Cost. Insiders own 0.02%. PO: NA. 11/91, 9/89, & 2/86,2-for-1 stock splits. 2/00, Company formed through merger with SmithKline Beecham plc @ 1 ADR-for-1.138 ADS of GSK and Glaxo Wellcome plc @ 1.
| Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com